Allogene Therapeutics Inc (ALLO)
1.4050 -0.0350 (-2.43%) 13:35 ET [NASDAQ]
1.4000 x 1045 1.4100 x 1681
Realtime by (Cboe BZX)
1.4000 x 1045 1.4100 x 1681
Realtime 1.3900 -0.0500 (-3.47%) 09:29 ET
for Thu, Apr 3rd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -257,590 | -327,265 | -340,414 | -182,051 | -316,381 |
| Depreciation Amortization | 5,291 | 7,390 | 17,186 | 17,409 | 10,836 |
| Accounts payable and accrued liabilities | -503 | -7,502 | 4,868 | -767 | 615 |
| Other Working Capital | -24,799 | -21,307 | 3,897 | -31,949 | 53,922 |
| Other Operating Activity | 77,301 | 110,951 | 93,944 | 12,546 | 135,915 |
| Operating Cash Flow | $-200,300 | $-237,733 | $-220,519 | $-184,812 | $-115,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -694 | -1,516 | -5,191 | -21,446 | -65,958 |
| Purchase Of Investment | -361,475 | -438,629 | -248,109 | -543,293 | -1,037,591 |
| Sale Of Investment | 437,857 | 603,434 | 359,459 | 728,394 | 598,426 |
| Investing Cash Flow | $75,688 | $163,289 | $106,159 | $163,655 | $-505,123 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 114,395 | 95,695 | 2,950 | 11,963 | 633,591 |
| Other Financing Activity | 2,280 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $116,675 | $95,695 | $2,950 | $11,963 | $633,591 |
| Beginning Cash Position | 93,447 | 72,196 | 183,606 | 192,800 | 179,425 |
| End Cash Position | 85,510 | 93,447 | 72,196 | 183,606 | 192,800 |
| Net Cash Flow | $-7,937 | $21,251 | $-111,410 | $-9,194 | $13,375 |
| Free Cash Flow | |||||
| Operating Cash Flow | -200,300 | -237,733 | -220,519 | -184,812 | -115,093 |
| Capital Expenditure | -694 | -1,516 | -5,191 | -21,446 | -65,958 |
| Free Cash Flow | -200,994 | -239,249 | -225,710 | -206,258 | -181,051 |